3-FPM 60 MG -pellettiä

3-FPM 60mg Pellets – Optimized Formulation for Stimulating Research

fpm 3

Core specifications

• Pellettiä kohden:  60 mg 3-FPM (3-fluorofeenimetratsiini)

• Puhtaus:  ≥99% (GC-MS confirmed)

• Formulation:  Hydrophilic matrix for rapid dissociation

• Stability:  36 months at 15-25°C (sealed packaging)

Tieteelliset sovellukset

Neuropharmacological Studies

• Dopamine/norepinephrine reuptake inhibition

• Comparative duration of action versus related stimulants

• Locomotor activity modulation

Chemical Characterization

• Fluorine-aromatic interaction analyses

• Metabolite profile in hepatocyte cultures

• Structural activity relationships within the phenmetrazine class

Advanced Laboratory Guidelines

Experimental Optimization

• In vitro absorption:  Use Caco-2 cell model at pH 6.8

• Dose conversion:  0.5mg/kg (rat) ≈ 0.08mg/kg (human equivalent)

• Analytical separation:  HILIC-HPLC method available

Vakaustiedot

• Photostability: <1% degradation after 500 lux hours

• Thermal stability: Decomposition temperature 218°C

Turvallisuusprotokolla

Hazard classification:

• H302: Harmful if swallowed

• H332: Harmful if inhaled

Kriittiset valvontapisteet:

1. Air monitoring in powder processing

2. Double glove policy (nitrile over latex)

3. Explosion-proof refrigerator for storage

Ordering modalities

Standard configurations:

• Basic research kit (25 pellets)

• Institutional package (250 pellets) with ISO-17025 certified analysis

Premium Options:

• Deuterium-labeled internal standard (+€125/batch)

• GMP clinical trial formulation (on request)

Regulatory Framework

CAS Registration:

• 3-FPM: [Enter CAS number here]

EU Classification:

• No harmonized classification under CLP

• Not included in the Dutch Opium Act

Technical Services Package

Research support:

• In-silico docking studies (additional €250/project)

• Microsome stability screening

• QSAR model validation

Analytical Services:

• Chirality analysis (ee >99%)

• Jäännösliuottimen profilointi (USP <467>)

Ethics Statement:
This product is only intended for:
☑Preclinical research
☑Analytical methodology development
☑Pharmacokinetic modeling

Not suitable for:
☒ Human consumption
☒ Animal testing without ethical approval
☒ Recreational uses. 1V-LSD 150 MCG -näytteenotot O-DSMT 50 mg -pelletit 1cP-LSD 150 MCG taidepaperia Osta ibogaiinihydrokloridia Ibogan juuren kuori